2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 282 | 9.316 | 12.418 | 17.228 | 38.314 | 40.710 |
Total Income - EUR | - | - | - | - | 282 | 9.316 | 14.419 | 17.228 | 38.316 | 40.721 |
Total Expenses - EUR | - | - | - | - | 2.202 | 8.645 | 15.936 | 13.488 | 17.173 | 16.210 |
Gross Profit/Loss - EUR | - | - | - | - | -1.920 | 671 | -1.518 | 3.740 | 21.142 | 24.511 |
Net Profit/Loss - EUR | - | - | - | - | -1.928 | 391 | -1.639 | 3.568 | 20.759 | 24.104 |
Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Adebiospices S.r.l.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 0 | 0 | 0 | 319 | 325 | 331 | - | - | - | - |
Current Assets | - | - | - | - | 672 | 2.779 | 1.777 | 3.806 | 22.839 | 20.271 |
Inventories | - | - | - | - | 441 | 163 | 410 | 253 | 64 | 6 |
Receivables | - | - | - | - | 117 | 814 | 59 | 496 | 417 | 2.449 |
Cash | - | - | - | - | 114 | 1.802 | 1.308 | 3.057 | 22.357 | 17.816 |
Shareholders Funds | - | - | - | - | -1.885 | -1.457 | -3.069 | 567 | 19.193 | -17.841 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 2.888 | 4.562 | 5.164 | 3.239 | 3.645 | 38.113 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7739 - 7739" | |||||||||
CAEN Financial Year | 4637 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.